Term
|
Definition
nicotinic receptor agonist that causes skeletal muscle relaxation |
|
|
Term
|
Definition
nicotinic receptor antagonist that causes skeletal muscle relaxation |
|
|
Term
Succinylcholine properties |
|
Definition
immediate muscle fasciculations (waves of muscle contractions) lasting 1 minute muscle relaxation for about 1 minute rapid recovery 5-10 minutes hydrolyzed by plasma cholinesterases not acetylcholine esterase like Ach |
|
|
Term
Succinylcholine therapeutic uses: |
|
Definition
uses: endotracheal intubation, brief procedures, electroconvulsive shock for depression MOA: neuromuscular blockade to get tube in |
|
|
Term
succinylcholine effects on the cardiovascular system |
|
Definition
low doses: effect PNS and decrease HR high doses: can also activate the sypathetic ganglia which increases HR and BP |
|
|
Term
competative neuromuscular blocking drugs: Curare properties (prototype) (goals for curure based drugs) |
|
Definition
onset and duration: 5 minutes; 1-2 hours - causes ganglionic blockade leading to hypotension and tachycardia -causes histamine release leading to hypotension and bronchiospasm -metabolized in liver and eliminated via kidney |
|
|
Term
Pancurium properties (unlike curare) |
|
Definition
does not: block ganglionic nicotinic receptors or stimulate histamine release so it does not cause hypotension or tachycardia BUT it blocks muscarinic receptors so it can cause tachycardia by blocking muscles of the heart |
|
|
Term
|
Definition
has a shorter onset and duration than pancurium does not: Block ganglionic nicotinic receptors Stimulate histamine release Block muscarinic receptor (unlike Pancuronium) this is the best drug because it cant cause hypotension or tachycardia |
|
|
Term
Ganglionic blocking Drugs: Mecamylamine |
|
Definition
|
|
Term
|
Definition
CNS: Psycho Stimulant or Relaxant cardiovascular: Small Increase in BP for brief periods can cause atherosclerosis Increase in HR Gastrointestinal: PNS Nausea, Diarrhea, vomiting, salivation |
|
|
Term
|
Definition
Chantix It is a partial agonist selective for alpha4 beta2 nicotinic receptor Stimulated dopamine release because this is the receptor present Partial agonist binds to nicotinic receptor and produces some activation of the receptor (suppress cravings) |
|
|
Term
Potential Therapeutic Uses for Nicotine |
|
Definition
1) Parkinson's and Alzheimer's diseases 2) cognitive performance 3) pain 4) schizophrenia |
|
|